Xia J - Search Results

1

Abnormally high HIP1 expression is associated with metastatic behaviors and poor prognosis in ESCC.

Sun Y, Zhou Y, Xia J, Wen M, Wang X, Zhang J, Zhang Y, Zhang Z, Jiang T. Sun Y, et al. Among authors: xia j. Oncol Lett. 2021 Feb;21(2):79. doi: 10.3892/ol.2020.12340. Epub 2020 Nov 30. Oncol Lett. 2021. PMID: 33363616 Free PMC article.

2

Detection of EML4-ALK fusion gene and features associated with EGFR mutations in Chinese patients with non-small-cell lung cancer.

Wen M, Wang X, Sun Y, Xia J, Fan L, Xing H, Zhang Z, Li X. Wen M, et al. Among authors: xia j. Onco Targets Ther. 2016 Apr 5;9:1989-95. doi: 10.2147/OTT.S100303. eCollection 2016. Onco Targets Ther. 2016. PMID: 27103824 Free PMC article.

3

Inhibiting CREPT reduces the proliferation and migration of non-small cell lung cancer cells by down-regulating cell cycle related protein.

Liu T, Li WM, Wang WP, Sun Y, Ni YF, Xing H, Xia JH, Wang XJ, Zhang ZP, Li XF. Liu T, et al. Am J Transl Res. 2016 May 15;8(5):2097-113. eCollection 2016. Am J Transl Res. 2016. PMID: 27347318 Free PMC article.

4

Correlation of EGFR Del 19 with Fn14/JAK/STAT signaling molecules in non-small cell lung cancer.

Sun Y, Han Y, Wang X, Wang W, Wang X, Wen M, Xia J, Xing H, Li X, Zhang Z. Sun Y, et al. Among authors: xia j. Oncol Rep. 2016 Aug;36(2):1030-40. doi: 10.3892/or.2016.4905. Epub 2016 Jun 23. Oncol Rep. 2016. PMID: 27350337

5

Li W, Zheng G, Xia J, Yang G, Sun J, Wang X, Wen M, Sun Y, Zhang Z, Jin F. Li W, et al. Among authors: xia j. Cancer Sci. 2018 Apr;109(4):1012-1023. doi: 10.1111/cas.13524. Epub 2018 Mar 5. Cancer Sci. 2018. PMID: 29397041 Free PMC article.

6

EGFR mutations subset in Chinese lung squamous cell carcinoma patients.

Sun Y, Yin X, Wen MM, Zhang J, Wang XJ, Xia JH, Zhang YN, Zhang ZP, Li XF. Sun Y, et al. Among authors: xia jh. Mol Med Rep. 2018 Jun;17(6):7575-7584. doi: 10.3892/mmr.2018.8859. Epub 2018 Apr 5. Mol Med Rep. 2018. PMID: 29620244 Free PMC article.

7

Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation.

Wen M, Xia J, Sun Y, Wang X, Fu X, Zhang Y, Zhang Z, Zhou Y, Li X. Wen M, et al. Among authors: xia j. Biologics. 2018 Nov 30;12:183-190. doi: 10.2147/BTT.S169305. eCollection 2018. Biologics. 2018. PMID: 30555222 Free PMC article.

8

CHCHD2 is a potential prognostic factor for NSCLC and is associated with HIF-1a expression.

Yin X, Xia J, Sun Y, Zhang Z. Yin X, et al. Among authors: xia j. BMC Pulm Med. 2020 Feb 13;20(1):40. doi: 10.1186/s12890-020-1079-0. BMC Pulm Med. 2020. PMID: 32054470 Free PMC article.

9

Optimal Adjuvant Therapy in Resected Stage IIIA-N2 Non-Small-Cell Lung Cancer Harboring EGFR Mutations.

Wen M, Wang L, Wang X, Yang S, Sun Y, Xia J, Zhang Y, Zhang Z, Huang L, Jiang T. Wen M, et al. Among authors: xia j. Oncol Res Treat. 2020;43(12):686-693. doi: 10.1159/000506692. Epub 2020 Nov 16. Oncol Res Treat. 2020. PMID: 33197924

10

STYK1/NOK Promotes Metastasis and Epithelial-Mesenchymal Transition in Non-small Cell Lung Cancer by Suppressing FoxO1 Signaling.

Lai Y, Lin F, Wang X, Zhang J, Xia J, Sun Y, Wen M, Li X, Zhang Z, Zhao J. Lai Y, et al. Among authors: xia j. Front Cell Dev Biol. 2021 Jul 6;9:621147. doi: 10.3389/fcell.2021.621147. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34295886 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,684 results

Search Page

Filters